Opinion: Three former FDA officials: Here's what Trump and his nominees need to know

There has been much speculation about what is in store for the Food and Drug Administration in the incoming administration, as President Trump and his likely nominees for senior health positions — including Robert F. Kennedy Jr. for secretary of Health and Human Services and Marty Makary for FDA commissioner — have expressed strong views about how the FDA regulates our nation’s foods, drugs/devices, and cosmetics.  RFK Jr. has called for a major shakeup at FDA.

Every new administration brings in senior officials who want to put their own imprimatur on their agencies. We expect the new appointees will seek to do the same at the FDA. We will find out more about their plans at the confirmation hearings for Kennedy and Makary and as new senior officials are appointed. Change at the FDA is a constant as the agency evolves to address new products and challenges. We welcome thoughtful change intended to better position the FDA to meet today’s and future challenges.

Read the rest…